Cubist Systematic Strategies, LLC Organon & Co. Call Options Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$13.78 - $18.8 $1.84 Million - $2.51 Million	-133,600 Reduced 75.61%	43,100 $810,000
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $1.46 Million - $2.3 Million	133,000 Added 304.35%	176,700 $2.55 Million
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $350,049 - $501,547	21,100 Added 93.36%	43,700 $758,000
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $435,502 - $556,638	22,600 New	22,600 $470,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.